Skip to main content

CITADEL ADVISORS LLC

Position in CGON — CG Oncology, Inc.

CIK 1423053 MIAMI, FL

Position in CGON

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$11,696,119 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
10 quarters on record

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Derivatives in CGON

reported options exposure · as of Jun 30, 2026
CallValue
$10,600,660
CallShares
149,200
PutValue
$703,395
PutShares
9,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CGON

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $703,395 9,900
2026-06-30 $10,600,660 149,200
2026-03-31 $2,483,856 36,700
2026-03-31 $3,945,744 58,300
2026-03-31 $11,696,119 172,815
2025-12-31 $2,503,656 60,300
2025-12-31 $1,511,328 36,400
2025-12-31 $28,282,842 681,186
2025-09-30 $265,848 6,600
2025-09-30 $9,617,736 238,772
2025-09-30 $902,272 22,400
2025-06-30 $4,556,578 175,253
2025-06-30 $1,315,600 50,600
2025-06-30 $943,800 36,300
2025-03-31 $66,123 2,700
2025-03-31 $27,892,100 1,138,918
2025-03-31 $771,435 31,500
2024-12-31 $33,534,175 1,169,253
2024-12-31 $989,460 34,500
2024-12-31 $435,936 15,200
2024-09-30 $762,146 20,200
2024-09-30 $12,125,025 321,363
2024-06-30 $514,591 16,300
2024-06-30 $15,522,779 491,694
2024-03-31 $12,136,637 276,461
2024-03-31 $87,800 2,000